Indian Journal of Clinical Biochemistry

, Volume 21, Issue 2, pp 100–102 | Cite as

Lipid profile in leukemia and Hodgkin's disease

  • P. P. Naik
  • M. S. Ghadge
  • A. S. Raste


A number of epidemiologic studies has been published in recent years showing an increase risk of death from cancer in subjects with low plasma cholesterol levels. Although several authors proposed that hypocholesterolemia is predisposing factor for cancer development, no causative relation has been established so far and that it may be that low plasma cholesterol is secondary to malignant disease. Hence, the present study was undertaken to examine the lipid profile in children patients with leukemia and Hodgkin's disease in comparison with age matched controls. The study included 52 normal healthy controls and 105 patients with leukemia and Hodgkin's disease. Lipid profile included serum cholesterol, HDL & LDL cholesterol and triglycerides. Serum cholesterol, HDL & LDL cholesterol were found to be inversely associated with incidence of cancer, whereas triglycerides were significantly elevated in cancer patients. The inverse association between cancer and serum cholesterol may reflect a physiological response to early undiagnosed stages of cancer.

Key words

Blood lipids Leukemia Hodgkin's disease 


Unable to display preview. Download preview PDF.

Unable to display preview. Download preview PDF.


  1. 1.
    Feinleib, M. (1983) Review of the epidemiological evidence for a possible relationship between hypocholesterolemia and cancer. Cancer Res. 43, 2503–2507.Google Scholar
  2. 2.
    Kreger, B.E., Anderson, K.M., Schatzkui, A. and Splansky, G.L. (1992) Serum cholesterol levels, body mass index and the risk of colon cancer. Cancer 70, 1038–1043.PubMedCrossRefGoogle Scholar
  3. 3.
    Rao, K.N., Kottapally, S., Eskander, E.D., Shinozuka, H., Dessi, S. and Pani, P. (1986) Acinar cell carcinoma of rat pancreas: regulation of cholesterol esterification. Br. J. Cancer 25, 305–310.Google Scholar
  4. 4.
    Dessi, S., Batetta, B., Anchisi, C. et al. (1992) Cholesterol metabolism during the growth of a rat ascites hepatoma (Yoshida AH-130). Br. J. Cancer 66, 787–793.PubMedGoogle Scholar
  5. 5.
    Dessi, S., Batetta, B., Pulisci, D., Accogli, P., Pani, P. and Broccia, G. (1991) Total and HDL cholesterol in human hematologic neoplasms. Int. J. Hematol. 54, 483–486.PubMedGoogle Scholar
  6. 6.
    Gilbert, H.S. and Ginsberg, H. (1984) Hypocholesterolemia as a manifestation of disease activity in chronic myelogenous leukemia. Cancer 51, 1428–1433.CrossRefGoogle Scholar
  7. 7.
    Reverter, J.C., Sierra, J., Marti Tutusaus, J.M., Montserrat, E., Granena, A. and Rozman, C. (1988) Hypocholesterolemia in acute myelogenous leukemia. Eur. J. Haematol. 41, 317–320.PubMedCrossRefGoogle Scholar
  8. 8.
    Nomura, A.M., Stemmermann, G.N. and Chyon, P.H. (1991) Prospective study of serum cholesterol levels and large bowel cancer. J. Natl. Cancer Inst. 83, 1403–1407.PubMedCrossRefGoogle Scholar
  9. 9.
    Umeki, S. (1993) Decrease in serum cholesterol levels in advanced lung cancer. Respiration 60(3), 178–181.PubMedCrossRefGoogle Scholar
  10. 10.
    Avall-Lundqvist, E.H. and Peterson, C.O. (1996) Serum cholesterol and apolipoprotein B levels may reflect disease activity in ovarian cancer patients. Acta. Oncol. 35(8), 1007–1010.PubMedCrossRefGoogle Scholar
  11. 11.
    Sigurd, V., Magnus, B., Gosta G. and Curt P. (1985) Hypocholesterolemia in malignancy due to elevated low density lipoprotein receptor activity in tumor cells: Evidence from studies inpatients with leukemia. The Lancet. 23, 1150–1154.Google Scholar
  12. 12.
    Silvia B., Donata S., Cecilia Z., Livio P., Giuseppe L. and Bruno G. (1996) Prognostic relevance of lipoprotein cholesterol levels in acute lymphocytic and non lymphocytic leukemia. Acta Haematol. 96, 24–28.Google Scholar
  13. 13.
    Friedewald, W.T., Levy, R.I. and Friedrickson, D.S. (1972) Estimation of the concentration of Low density lipoprotein cholesterol in plasma, without use of the preparative ultracentrifuge. Clin. Chem. 18, 499–502.PubMedGoogle Scholar
  14. 14.
    Musolino, C., Calabro, L., Bellomo, G., Cincotta, M., DiGiacomo, V., Pezzano, B., Rizzo, V., Guglielmo, S. and Alonci, A. (2002) Lipid profile in haematologic neoplasms. Recenti Prog. Med. 93(5), 298–301.PubMedGoogle Scholar
  15. 15.
    Fiorenza, A.M., Branchi, A. and Sommariva, D. (2000) Serum lipoprotein profile in patients with cancer. A comparison with non-cancer subjects. Int. J. of Clin. and Lab. Res. 30(3), 141–145.CrossRefGoogle Scholar
  16. 16.
    Zyada, L.E., Hassan, H.T., Rees, J.K. and Ragab, M.H., (1990) The relationship between hypocholesterolemia and degree of maturation in acute myeloid leukemia. Hematol. Oncol. 8(1), 65–69.PubMedCrossRefGoogle Scholar
  17. 17.
    Peterson, C., Vitol, S., Rudling, M., Blomgren, H. and Skoog, L. (1985) Hypocholesterolemia in cancer patients may be caused by elevated LDL receptor activities in malignant cells. Med Oncol Tumor Pharmacother. 2(3), 143–147.PubMedGoogle Scholar
  18. 18.
    Budd, D. and Ginsberg, H. (1986) Hypocholesterolemia and acute myelogenous leukemia. Cancer 58, 1361–1365.PubMedCrossRefGoogle Scholar
  19. 19.
    Pandolfino, J., Hakimian, D., Rademaker, A.W. and Tallman, M.S. (1997) Hypocholesterolemia in hairy cell leukemia: a marker for proliferative activity. Am. J. Haematol. 55(3), 129–133.CrossRefGoogle Scholar

Copyright information

© Association of Clinical BIochemists of India 2006

Authors and Affiliations

  • P. P. Naik
    • 1
  • M. S. Ghadge
    • 1
  • A. S. Raste
    • 1
  1. 1.Department of BiochemistryTata Memorial HospitalMumbai

Personalised recommendations